Article
Combined phenotype of 4 markers improves prognostic value of patients with colon cancer.
The American journal of the medical sciences - 1 Apr 2012
Liu Caiyun, Qu Like, Dong Bin, Xing Xiaofang, Ren Tingting, Zeng Yan, Jiang Beihai, Meng Lin, Wu Jian, Shou Chengchao
Abstract excerpt
INTRODUCTION: Combination of multiple biomarkers representing distinct aspects of tumor biology will have a better prognostic value. This study was to identify prognostic subgroups of colon adenocarcinoma by combined analysis of synuclein-gamma (SNCG), a human homologue of piwi (Hiwi), phosphatase of regenerating liver-3 (PRL-3), arrest-defective protein 1, homolog A (ARD1) and clinicopathologic features in 225...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.